High dose ifosfamide, doxorubicin, dacarbazine and G-CSF for patients with metastatic or locally advanced soft tissue sarcoma

Chinese Journal of Cancer Research

Volumn 11, Issue 3, 1999, Pages 200-203

  Lin, T Y ^a   Guang, Z Z ^a   Su, Y S ^a   Zhou, Z M ^a   Liu, D G ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Chemotherapy; High dose; Ifosfamide; Soft tissue sarcoma

Indexed keywords

DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FIBROSARCOMA; HEMANGIOPERICYTOMA; HEMATURIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEIOMYOSARCOMA; LEUKOCYTE COUNT; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MUCOSA INFLAMMATION; NEUROFIBROSARCOMA; NEUTROPENIA; PILOT STUDY; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SURVIVAL TIME; SYNOVIAL SARCOMA; VOMITING;

EID: 0032887007     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-999-0012-0     Document Type: Article

References (11)